Trexquant Investment LP acquired a new position in shares of Sotera Health (NASDAQ:SHC - Free Report) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 279,211 shares of the company's stock, valued at approximately $3,820,000. Trexquant Investment LP owned about 0.10% of Sotera Health at the end of the most recent reporting period.
Other hedge funds also recently added to or reduced their stakes in the company. Geode Capital Management LLC grew its holdings in Sotera Health by 19.4% in the 3rd quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company's stock worth $46,026,000 after buying an additional 447,186 shares in the last quarter. Neo Ivy Capital Management bought a new position in shares of Sotera Health in the third quarter worth $720,000. Barclays PLC increased its holdings in shares of Sotera Health by 169.8% during the third quarter. Barclays PLC now owns 473,597 shares of the company's stock valued at $7,909,000 after purchasing an additional 298,085 shares during the period. SG Americas Securities LLC raised its stake in shares of Sotera Health by 271.6% during the fourth quarter. SG Americas Securities LLC now owns 36,364 shares of the company's stock valued at $497,000 after purchasing an additional 26,577 shares in the last quarter. Finally, KBC Group NV lifted its holdings in Sotera Health by 4,094.6% in the fourth quarter. KBC Group NV now owns 186,365 shares of the company's stock worth $2,549,000 after purchasing an additional 181,922 shares during the period. 91.03% of the stock is currently owned by institutional investors.
Sotera Health Price Performance
Shares of Sotera Health stock traded down $0.09 during trading on Friday, hitting $10.51. The stock had a trading volume of 1,456,650 shares, compared to its average volume of 1,197,216. The business has a fifty day moving average of $12.15 and a two-hundred day moving average of $13.52. Sotera Health has a fifty-two week low of $9.53 and a fifty-two week high of $17.08. The firm has a market cap of $2.98 billion, a P/E ratio of 42.04 and a beta of 1.88. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61.
Analyst Ratings Changes
Separately, Barclays lowered their target price on shares of Sotera Health from $16.00 to $12.00 and set an "overweight" rating on the stock in a research note on Thursday. Two equities research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $15.20.
Read Our Latest Stock Report on SHC
Sotera Health Company Profile
(
Free Report)
Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.
Featured Articles
Before you consider Sotera Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sotera Health wasn't on the list.
While Sotera Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
